Home

Ranbaxy has received final approval from USFDA to market Famotidine tablets.

suniljain's picture
Submitted by suniljain on November 19, 2009 - 12:37

Shares of Ranbaxy Laboratories are trading at Rs 428.80, up Rs
6.5, or 1.54% at the Bombay Stock Exchange (BSE).

The company has received final approval from United States Food & Drug
Administration (USFDA) to market Famotidine tablets on over-the-counter basis. 

News URL:http://www.myiris.com/newsCentre/storyShow.php?fileR=20091119120832199&dir=2009/11/19&secID=livenews

»

Recent Comments and talks

What is AskDalal ?

AskDalal is a investment blogging portal dedicated to Indian investment community , where every blog answers a question.It may be stocks, bonds,commodity, real estate or anything else.Post your blog title  or a question, community will do research and answer the question to give you your own research report.It is 100%free , no registration is required to browse and ask questions.It's great for writers looking for article topic,and cool for investor looking for answers.

>>> faq

Top Contributors

UserPoints
suniljain10,440
admin2,990
rahul das2,460
anilmehta1,710
dipak1,540
rakeshseth1,500
himesh1,350
stockguru1,110
shah1,060
bharat_vora1,040
more

Become Askdalal Research Analyst

Are you an MBA (finance) students, economics students, or journalist with broad interest in stocks, investing and finance. Do you want to polish your skills before getting into job market ? Come join askdalal as Research Analyst.Email your resume to tripti.shah@askdalal.com.

If your resume is impressive you will get chance to show your talent,polish your skills and earn money along the way. At the convenience of sitting at your home computer. See rules for askdalal investment analyst.

Latest Dalal

  • rosenjack13
  • bangalore.scrap
  • bipin1987310
  • mohammed ilyas
  • mehta.a10